1. All Products
  2. CLOFAZIMINE, 100mg, soft caps.
Public Pricelist

CLOFAZIMINE, 100mg, soft caps.

https://medicalguidelines.msf.org/en/node/1213
https://unicat.msf.org/cat/product/11951
STD DORACLOF1C-

Valid Article

6.2.4 - Antileprosy medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04BA01
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

CLOFAZIMINE

Therapeutic Action

Antileprotic and antituberculosis

Indications

Paucibacillary and multibacillary leprosy, in combination with rifampicin and dapsone

Drug-Resistant Tuberculosis (DR-TB), in combination with other TB medicines

Some restricted information has been hidden. Sign in to see this information

Instructions for use

The 50 mg tablet and caps are intended for paediatric use.

Must be taken with food to improve gastrointestinal tolerance.

Protect the skin from sun.

Precautions for Use

May cause strong QT prolongation, orange-brown discolouration of skin and body fluids.

Storage

Below 25ºC - Protect from humidity